This website, as an activity funded by the U.S. Department of State is temporarily suspended. The website will remain live, but will not be monitored or updated.
This information will be updated with any change in circumstances. Thank you for your understanding.
This publication assesses various evidence-based treatments for Opioid Use Disorder and specifically highlights the effectiveness of medication-based treatment when done correctly.
Opioid Use disorder is one of the most challenging forms of addiction facing health care systems around the world. The treatment of opioid dependence is important to reduce its health and social consequences and to improve the well-being...
Opioid use disorder is a chronic, relapsing disease and a global health burden. Treatment for OUD tends to involve a combination of medication and behavioural intervention. It is recognised that buprenorphine can alleviate opioid withdrawal...
Recent studies carried out by researchers from Vanderbilt University and Johns Hopkins University have examined characteristics linked with the heightened risk NAS. The researchers found that boys are more likely to receive a diagnosis of...
It is vital that the treatment for individuals living with Opioid Use Disorder is of high quality and evidence-informed. The Canadian Centre on Substance Use and Addiction has launched a new report, Best Practices across the Continuum of...
Opioid Use Disorder (OUD), and the associated risk of overdose and death, is becoming one of the most prevalent threats to health and social wellbeing in the United States. Medication, such as buprenorphine, is the gold standard treatment...
Emergency departments are often the first point of contact for individuals who have overdosed or suffering from the effects of opioids. Despite the vital role practitioners within this service provide, there has been, up until now, little...
Abstract Purpose of Review: In light of the current crisis in opioid involved overdose deaths, the federal Department of Health and Human Services operating divisions are working together to implement a data-driven, research-based strategy...
ABSTRACT Background: Ibogaine is a monoterpene indole alkaloid used in medical and nonmedical settings for the treatment of opioid use disorder. Its mechanism of action is apparently novel. There are no published prospective studies of drug...